All Lawsuits
Open Consumer Products

Differin Acne Products Benzene Contamination Settlement - Up to $990K Available

vs. Galderma Laboratories LP

Est. Payout
9 - 27 dollars without receipts, unlimited with proof of purchase
Deadline
May 19, 2026
Views
5
Summary

Galderma Laboratories agreed to pay $990,000 to settle allegations that it failed to warn consumers about potential benzene contamination in certain Differin acne treatment products. The lawsuit claimed the company misled customers about the safety risks of these skincare items.

Details
The class action lawsuit alleged that Galderma Laboratories failed to adequately inform consumers about possible benzene contamination in three specific Differin acne products. Benzene is classified as a known human carcinogen that has been linked to leukemia and other serious blood disorders. The settlement covers consumers who purchased the affected products during a six-year period. Class members can receive compensation ranging from $9 to $27 without receipts, or unlimited reimbursement with valid proof of purchase.
Who's Eligible?

Consumers who purchased Differin Daily Deep Cleanser (5% benzoyl peroxide), Differin Acne Spot Treatment (10% benzoyl peroxide), or Differin Maximum Strength Acne Foaming Cleanser (10% benzoyl peroxide) between January 1, 2020, and February 19, 2026, nationwide

File Your Claim